GSK343 decreased tumor stemness. by Laura V. Bownes (10276762)

“…<p>(A) COA3 and (B) COA6 PDX cells were plated as single cell suspension in serum-free, conditioned media onto 96-well low attachment plates using serial dilutions with 5000, 1000, 100, 50, 20, 10, and 1 cell per well. Cells were treated with GSK343 (0, 5 μM). …”

Rapamycin decreases Schwann cell markers, whereas statin induces Schwann cell markers. by Andrea Preitschopf (629851)

FoxM1 knockdown increases, and overexpression decreases, differentiation-associated marker expression in primary GBM cells. by Yeri Lee (539375)

The PRAME-AS knockout cells showed a decrease in migration, proliferation, stemness, and viability. by Zahra Hosseininia (22265113)

MSCs decrease lung inflammation. by Konrad Urbanek (439073)

SLE decreases risk for hormonal cancers. by Deborah K. Johnson (10001156)

“…(b) Prostate cancer incidence in male SLE cohort is significantly decreased by SLE status (OR 0.23, 95% CI 0.089, 0.50, p = 0.0053).…”

The decrease in hBMVEC death is associated with reduced activation of Caspase-3. by Simona F. Spampinato (773594)

Deletion of STX1B decreases frequency of mEPSCs and mIPSCs. by Tatsuya Mishima (529071)

Ketamine decreases NSC viability in a dose-dependent manner. by Shiva Mansouri (2838086)

Rg3 decreases HDAC3 expression. by Xiu Shan (62157)

CD47 expression is decreased in hematopoietic progenitor cells in patients with myelofibrosis by A. Nonino (6072632)

“…We compared CD47 expression in hematopoietic stem and progenitor cells of patients with MF and controls and found it to be decreased in progenitors of MF. …”

Decreased type I IFN response in B cells carrying the MS-protective class I alleles. by Christian Lundtoft (4068679)

Correlation between decreased ferroportin (Fpn) protein level and increased hepcidin (Hepc) mRNA expression in the liver of <i>ms/−</i> males. by Małgorzata Lenartowicz (150659)

Decreased ISCs and increased goblet cells after intestinal specific loss of MLL1. by Neha Goveas (11790822)

“…Right panels; enteroendocrine cells stained with chromogranin A antibody (brown; arrowheads) in the villi. Scale bars are 100 μm. (E) Left and middle panels; antibody stainings showed reduced OLFM4 and Ki67 expression in <i>Mll1</i>^{<i>FC/FC; Vil-Cre-ERT2/+</i>} intestine compared to controls, one week after the first gavage. …”

Running increased neural stem cell proliferation in the dentate gyrus, but did not decrease inflammation. by Kaja Falkenhain (9317016)

<i>Nanos1</i>⁺ cells in the bulb decrease after X-ray irradiation or drug treatments. by Sosuke Fujita (17691623)

Therapeutic administration of mMSCs failed to decrease pulmonary inflammation or modify BAL inflammatory cell counts in experimental severe influenza. by Ilyse Darwish (446378)

Root cell wall proteins with significant decreased in expression level under 50 µM Cu treatment identified by LC-ESI-MS/MS-based proteomics using SIEVE (<i>p</i><0.05 and fold chang >1.5). by Tingting Liu (267387)

“…</p><p>Root cell wall proteins with significant decreased in expression level under 50 µM Cu treatment identified by LC-ESI-MS/MS-based proteomics using SIEVE (<i>p</i><0.05 and fold chang >1.5).…”

Taste bud cell populations are decreased after <i>Sox2</i> deletion in epithelial stem/progenitor cells. by Makoto Ohmoto (3065106)

Cell adhesion to fibronectin is decreased with 50 µM 4N1K treatment. by Pascal Leclair (566971)